Macrophage-inflammatory protein-1alpha receptor expression on normal and chronic myeloid leukemia CD34+ cells

Area of Science:

• Hematology
• Immunology
• Cell Biology

Background:

• CD34+ cells are crucial hematopoietic stem and progenitor cells.
• Macrophage-inflammatory protein-1alpha (MIP-1alpha) is a chemokine involved in cell regulation.
• Chronic myeloid leukemia (CML) is characterized by aberrant cell proliferation.

Purpose of the Study:

• To investigate MIP-1alpha binding site expression on CD34+ cells from normal bone marrow (NBM) and CML.
• To determine the role of MIP-1alpha receptor expression in CML pathophysiology.
• To assess the potential of CD34+ cells as targets for HIV-1 infection via CCR5.

Main Methods:

• Flow cytometry was used to assess MIP-1alpha binding sites on CD34+ cells.
• Phenotypic characterization of receptor-bearing cells was performed using Thy-1 antigen.
• Antibodies against CCR5 were used to evaluate HIV-1 receptor expression.

Main Results:

• A small subpopulation of CD34+ cells in NBM and CML expressed MIP-1alpha surface binding sites.
• These receptor-bearing cells were identified as committed progenitors (Thy-1 negative).
• Significantly higher percentage of MIP-1alpha-R+ cells were found in NBM compared to CML, suggesting impaired chemokine response in CML.
• Very few CD34+ cells expressed CCR5, primarily on CD34+ Thy- progenitors.

Conclusions:

• MIP-1alpha binding sites are not constitutively expressed on most primitive multipotent stem cells.
• Reduced MIP-1alpha receptor expression on CML CD34+ cells may contribute to their altered response to this chemokine.
• Resting primitive multipotent cells are unlikely targets for HIV-1 infection through CCR5.